Cabergoline versus bromocriptine for the treatment of giant prolactinomas: A quantitative and systematic review
Year: 2018
Type: review
Source: Metabolic Brain Disease
Institutions: Shanghai Jiao Tong University, Ruijin Hospital
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Awards: G1819562909, G223008197, G8365443130
OpenAlex ID: W2792062815
